Grants and Contributions:
Title:
Vaccine Raw Materials & Lipid Manufacturing in Canada
Agreement Number:
819504
Agreement Value:
$15,000,000.00
Agreement Date:
Feb 4, 2023 - Dec 31, 2025
Description:
This project is to build a Good Manufacturing Practices (GMP) facility to manufacture lipids, conduct lipid nanoparticle (LNP) formulation and expand the company's existing vaccine manufacturing capacity in Calgary, AB.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
This investment will create national ecosystems and secure economic, innovation and public benefits, while strengthening Canada's epidemic and pandemic preparedness by growing a strong, competitive domestic life sciences sector.
Location:
Calgary, Alberta, CA T2A7H8
Reference Number:
033-2023-2024-Q2-819504
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
717183537
Recipient Type:
For-profit organization
Additional Information:
This is partially repayable contribution
Recipient's Operating Name:
Northern RNA Inc.
Recipient's Legal Name:
Northern RNA Inc.
Federal Riding Name:
Calgary Forest Lawn
Federal Riding Number:
48006
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
339900